one mitochondrion mito-ico.fw many diseases

Sign up for email updates

 

 

OUR

STORIES

ABOUT

TEAMMITO

Are you at risk?

TAKE THE MITOTEST

Power us up

DONATE, FUNDRAISE, VOLUNTEER

Plug in

CONNECT, SHARE, JOIN

FACEBOOK 

Unable to display Facebook posts.
Show error

Error: Error validating access token: Session has expired on Sunday, 10-Feb-19 12:04:01 PST. The current time is Friday, 22-Feb-19 08:49:25 PST.
Type: OAuthException
Code: 190
Subcode: 463
Please refer to our Error Message Reference.

TWITTER

BREAKTHROUGH DESIGNATION FROM FDA | TK2 DEFICIENCY TREATMENT
Modis Therapeutics announced the FDA has granted Breakthrough Therapy designation to MT1621, Modis' investigational treatment for patients with thymidine kinase 2 deficiency (TK2d). To read... https://t.co/p2VTPBE6GS

Fun event coming up in Regina, thank you @powerof8mtb for putting this on!

Load More...